Director, HEOR Strategy - Oncology

Director, HEOR Strategy, CLL & Heme-Oncology (HEOR-S)

Responsibilities:
- Direct, develop, organize, and implement the Value & Evidence (V&E) strategy for Chronic Lymphocytic Leukemia (CLL) and disease adjacencies toward registration, PR&A, and market launch in compliance with regulations.
- Accountable for engagement and co-creation of holistic value evidence strategy with V&E pillars and cross-functional partners, including PCM deliverables, MHI Worldwide Scientific Plan, and Value & Evidence Plans (VEP).
- Direct design, conduct, and analysis of projects across multiple programs with V&E Centers of Excellence (PCOR, VAC, RWE, EPE, MPS); accountable for execution, budget, and meeting ethical, scientific, regulatory, commercial, and quality requirements.
- Communicate findings to internal/external stakeholders (e.g., Executive Leadership, HTAs/Payers, patient advocacy groups, KOLs).
- Develop and execute V&E product life-cycle and labeling strategies post-marketing.
- Support commercialization activities by facilitating obtaining/maintaining market access and growing/defending the market.
- Own end-to-end delivery of the V&E book of work (strategy development to content pull-through).
- Partner with MHI, IMAP, and relevant V&E pillars to accelerate global patient access.
- Shape CLL patient access policy environment with HTAs/payers, clinical practice guideline organizations, and US oncology pathway stakeholders.
- Establish external alliances to drive payer/pathway-centric evidence generation for pre- and post-launch assets.
- Develop and maintain CLL research partnerships with academic/community oncology centers and pathways.

Qualifications:
- MSc/MPH/MBA with 10+ years relevant experience, or PharmD/PhD with 7+ years in HEOR, market access, or related research-focused field.
- Expertise in HEOR methods: health economic modeling, patient-reported outcomes, statistics, real-world evidence; registry/observational study design, execution, analysis, interpretation.
- Proven oncology HEOR and market access experience across pipeline, launch, in-line, and lifecycle management.
- Strong knowledge of oncology health technology development/commercialization (drugs and diagnostic devices).
- Demonstrated influence in matrixed environments; ability to align partners without direct authority.
- Track record with HTA/value assessment bodies (e.g., NCCN, ESMO-MCBS, NICE, IQWiG, CADTH, MSAC, ICER).
- Experience partnering with IDNs, GPOs, and collaborative groups.
- Ability to independently lead complex HEOR initiatives (e.g., SLRs, ITCs, NMAs, PRO/PED studies, RWE, DCEs, economic models, non-interventional studies).
- Strong strategic judgment, prioritization, and decision-making.
- Excellent English communication (oral/written) and interpersonal skills; strong internal/external partnership building.
- Strong project management skills (contracting, budgeting, vendor management).
- Highly organized, proactive, adaptable; bias for action in fast-moving environments.
- People leadership experience preferred.

Benefits (as stated):
- Paid time off (vacation, holidays, sick); medical/dental/vision insurance; 401(k) (eligible employees)
- Eligible for long-term incentive programs